| pubmed-article:12056962 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12056962 | lifeskim:mentions | umls-concept:C0278883 | lld:lifeskim |
| pubmed-article:12056962 | lifeskim:mentions | umls-concept:C0162835 | lld:lifeskim |
| pubmed-article:12056962 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:12056962 | lifeskim:mentions | umls-concept:C0879263 | lld:lifeskim |
| pubmed-article:12056962 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12056962 | pubmed:dateCreated | 2002-6-11 | lld:pubmed |
| pubmed-article:12056962 | pubmed:abstractText | Reports of vitiligo associated with metastases and rare cases of spontaneous regression of disease have fueled enthusiasm for immunologic approaches to the treatment of advanced melanoma. More recent strategies have focused on using antigen-presenting dendritic cells as vaccines. | lld:pubmed |
| pubmed-article:12056962 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12056962 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12056962 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12056962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12056962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12056962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12056962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12056962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12056962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12056962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12056962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12056962 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12056962 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12056962 | pubmed:issn | 0003-987X | lld:pubmed |
| pubmed-article:12056962 | pubmed:author | pubmed-author:TsaoHensinH | lld:pubmed |
| pubmed-article:12056962 | pubmed:author | pubmed-author:SoberArthur... | lld:pubmed |
| pubmed-article:12056962 | pubmed:author | pubmed-author:GoldbergMark... | lld:pubmed |
| pubmed-article:12056962 | pubmed:author | pubmed-author:HaluskaFrank... | lld:pubmed |
| pubmed-article:12056962 | pubmed:author | pubmed-author:HodiF... | lld:pubmed |
| pubmed-article:12056962 | pubmed:author | pubmed-author:MillmanPeriP | lld:pubmed |
| pubmed-article:12056962 | pubmed:author | pubmed-author:LinetteGerald... | lld:pubmed |
| pubmed-article:12056962 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12056962 | pubmed:volume | 138 | lld:pubmed |
| pubmed-article:12056962 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12056962 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12056962 | pubmed:pagination | 799-802 | lld:pubmed |
| pubmed-article:12056962 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:meshHeading | pubmed-meshheading:12056962... | lld:pubmed |
| pubmed-article:12056962 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12056962 | pubmed:articleTitle | Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanoma. | lld:pubmed |
| pubmed-article:12056962 | pubmed:affiliation | Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA. htsao@partners.org | lld:pubmed |
| pubmed-article:12056962 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12056962 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:12056962 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
